Giuliano M, Barza M, Jacobus N V, Gorbach S L
Antimicrob Agents Chemother. 1987 Feb;31(2):202-6. doi: 10.1128/AAC.31.2.202.
We compared the effects of four beta-lactam drugs with widely differing antibacterial and pharmacological properties on the composition of the intestinal flora. Cefoxitin, piperacillin, cefoperazone, and aztreonam were given intravenously for 9 days to healthy volunteers. Cefoperazone reduced the numbers of aerobic and anaerobic bacteria to undetectable levels. At the other extreme, cefoxitin had little effect on the normal flora. Aztreonam markedly reduced the numbers of aerobes, whereas piperacillin had a variable effect on both aerobic and anaerobic bacteria. There was extensive overgrowth of enterococci in subjects given cefoxitin or aztreonam, which have little activity against this species, and of yeasts in subjects given cefoperazone or piperacillin. Cefoperazone reached concentrations of 2,727 to 8,840 micrograms/g in the feces, whereas the other agents were generally undetectable. These results show that the new beta-lactam antibiotics produce widely varying effects on the fecal microflora after parenteral administration and that these effects are consistent with the antibacterial and pharmacological properties of the drugs.
我们比较了四种抗菌和药理特性差异很大的β-内酰胺类药物对肠道菌群组成的影响。将头孢西丁、哌拉西林、头孢哌酮和氨曲南静脉注射给健康志愿者,持续9天。头孢哌酮可将需氧菌和厌氧菌数量降至检测不到的水平。在另一个极端,头孢西丁对正常菌群几乎没有影响。氨曲南显著减少了需氧菌数量,而哌拉西林对需氧菌和厌氧菌均有不同程度的影响。接受头孢西丁或氨曲南治疗的受试者中肠球菌大量繁殖(这两种药物对该菌种几乎没有活性),接受头孢哌酮或哌拉西林治疗的受试者中酵母菌大量繁殖。头孢哌酮在粪便中的浓度达到2727至8840微克/克,而其他药物通常检测不到。这些结果表明,新型β-内酰胺类抗生素经肠胃外给药后对粪便微生物群产生的影响差异很大,且这些影响与药物的抗菌和药理特性一致。